Replies to post #7265 on InMed Pharmaceuticals Inc (INM)

[lesgetrich]

I expected the pps to drift down when they announced that 1 year delay in their business plan last summer. I just wasn't sure how low it would go. I think we've about seen the worst of the drift. I expect early next year, if not sooner, we'll start to see a reversal as expectations rise for commercialization of biosynthesis and the start of clinical trials. There just wasn't enough news this year to sustain the price.